'It still hurts, she said': Why pain medication may not be as effective for women as it is for men
- Date:
- March 17, 2025
- Source:
- University of Calgary
- Summary:
- A new study may help to explain why there is an over-representation of women experiencing chronic pain compared to men and why pain medication may not be as effective for women as it is for men. Findings show, male and females develop pain through different means.
- Share:
A new study led by University of Calgary professor Dr. Tuan Trang, PhD, may help to explain why there is an over-representation of women experiencing chronic pain compared to men. In 2019, the Canadian Pain Task Force report found chronic pain is more common among females of all ages, including children, when compared to males.
"Both males and females develop pain, but each sex develops it through different means," says Trang, a professor in the Faculty of Veterinary Medicine, and Cumming School of Medicine (CSM). "This study identifies a very unique type of biological process through a specific immune cell that is distinctive to each sex."
The study, published in Neuron, focused on neuropathic pain, which is caused by injury to a nerve or the nervous system. A debilitating symptom of this is allodynia which is experienced when someone feels pain from a stimulus that does not typically cause pain. This condition can be very hard to treat; for instance, things like a light touch, temperature changes, and clothing against the skin can be agonizing. The study, conducted in rats and mice, found that in both sexes pain signals can be communicated by pannexin 1 (Panx1) channels but through different types of immune cells. However, in female rodents, activation of Panx1 releases leptin, a hormone which has been associated with heightened pain sensitivity.
"Injury to a nerve can be debilitating," says Trang. "We know that a lot of preclinical research has been in male subjects. Consequently, treatments were often developed from a male-based understanding and may not be very effective in females."
Heightened levels of leptin in females experiencing chronic pain have been recorded in studies before. Trang notes that as far back as the 1980s, researchers who were working with human blood samples found that female patients experiencing chronic pain had higher levels of leptin in their blood than those who did not have chronic pain.
"In the clinic, we've known for many years that women are more likely than men to suffer from chronic pain, and it's often hard to know why some people respond to treatment and others don't," says Dr. Lori Montgomery, MD '03, pain clinician and clinical associate professor at the CSM. "Both sex and gender are important factors that need a lot more investigation, but this latest research might prove to be one of the ways that we can personalize treatment for patients so that it's more likely to be effective.
The first authors of this paper are Churmy Y. Fan, PhD, Brendan B. McAllister, PhD, and Sierra Stokes-Heck.
Story Source:
Materials provided by University of Calgary. Original written by Kelly Johnston. Note: Content may be edited for style and length.
Journal Reference:
- Churmy Y. Fan, Brendan B. McAllister, Sierra Stokes-Heck, Erika K. Harding, Aliny Pereira de Vasconcelos, Laura K. Mah, Lucas V. Lima, Nynke J. van den Hoogen, Sarah F. Rosen, Boram Ham, Zizhen Zhang, Hongrui Liu, Franz J. Zemp, Regula Burkhard, Markus B. Geuking, Douglas J. Mahoney, Gerald W. Zamponi, Jeffrey S. Mogil, Shalina S. Ousman, Tuan Trang. Divergent sex-specific pannexin-1 mechanisms in microglia and T cells underlie neuropathic pain. Neuron, 2025; DOI: 10.1016/j.neuron.2025.01.005
Cite This Page: